StockData
Altria Group, Inc. logo

Altria Group, Inc.

MONYSECigarettesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/304% above fair value
$77.17−0.86 (-1.10%)

Close on Nov 2, 2026Market cap $128.85BP/E 15.9Yield 5.39%

Altria FDA User Fees Included in Cost of Sales — Total by Year

FDA User Fees Included in Cost of Sales — Total ($M) ($M)

Altria FDA User Fees Included in Cost of Sales — Total: $250M in FY2025, down 1.6% from a year earlier.

Latest, FY2025
250
Period ended Dec 31, 2025
Change on a year earlier
-1.6%
254 in FY2024
History
12 years
Since FY2014
Sources
11
Documents cited below

Where the FY2025 figure comes from

“|| $ | 62 | $ | 60 | $ | 250 | $ | 254”

Source: Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000007), filed 2026-01-29 ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFDA User Fees Included in Cost of Sales — Total ($M) ($M)Year on yearSource
FY2025Dec 31, 2025250-1.6%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000007), filed 2026-01-29 ↗
FY2024Dec 31, 2024254-3.8%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000007), filed 2026-01-29 ↗
FY2023Dec 31, 2023264-4.0%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-25-000006), filed 2025-01-30 ↗
FY2022Dec 31, 2022275-1.1%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-24-000007), filed 2024-02-01 ↗
FY2021Dec 31, 2021278+150.5%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-23-000012), filed 2023-02-01 ↗
FY2020Dec 31, 2020111-62.1%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-22-000007), filed 2022-01-27 ↗
FY2019Dec 31, 2019293-67.1%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-21-000014), filed 2021-01-28 ↗
FY2018Dec 31, 2018890+215.6%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-20-000005), filed 2020-01-30 ↗
FY2017Dec 31, 2017282-1.1%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-19-000010), filed 2019-01-31 ↗
FY2016Dec 31, 2016285+3.6%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-18-000013), filed 2018-02-01 ↗
FY2015Dec 31, 2015275+7.4%Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-17-000010), filed 2017-02-01 ↗
FY2014Dec 31, 2014256–Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-16-000110), filed 2016-01-28 ↗

Breakdown

What makes up FDA User Fees Included in Cost of Sales — Total

Cite this data

StockData. (2026). Altria FDA User Fees Included in Cost of Sales — Total ($M), annual FY2014–FY2025 [Data set]. Compiled from Altria SEC filings and investor materials. https://stockdatahq.com/stocks/mo/kpis/fda-fees-total

See every metric in the Altria KPI table. Data updated Nov 2, 2026.